Patents by Inventor Caroline Weiser

Caroline Weiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense oligonucleotides against tenascin for the treating of vitiligo
    Publication number: 20050148017
    Abstract: Antisense oligonucleotides against tenascin for the treatment of vitiligo The invention relates to specific, optionally modified oligonucleotides having a length of up to 18 nucleotides, which correspond to sections of tenascin-coding sequences or can bind to these sequences, to their preparation and to the use thereof, for example for the specific inhibition of the expression of tenascin and for the production of pharmaceuticals which can be used for the treatment of vitiligo.
    Type: Application
    Filed: March 4, 2005
    Publication date: July 7, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Anuschirwan Peyman, Eugen Uhlmann, Caroline Weiser
  • Antisense oligonucleotides against tenascin for treating vitiligo
    Patent number: 6878547
    Abstract: The invention relates to specific, optionally modified oligonucleotides with a length of up to 17 nucleotides. Said oligonucleotides correspond to segments of tenascin-coding sequences or can bind to these sequences. The invention also relates to the production and use of the oligonucleotides, for example for the specific inhibition of the expression of tenascin and for producing medicaments used to treat vitiligo.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: April 12, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Anuschirwan Peyman, Eugen Uhlmann, Caroline Weiser